XML 68 R41.htm IDEA: XBRL DOCUMENT v3.8.0.1
Derivative Instruments (Tables)
3 Months Ended
Mar. 31, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Summary of fair value of derivatives instruments
The reported fair values of our derivatives, which are classified in Derivative instruments on our Consolidated Balance Sheets, were as follows:
 
March 31, 2018
 
December 31, 2017
Derivatives designated as hedging instruments:
 
 
 
  Long-term assets:
 
 
 
Interest rate swaps
$
12,733

 
$
6,046

  Long-term liabilities:
 
 
 
Net investment cross currency swaps
6,642

 
1,451

Derivatives not designated as hedging instruments:
 
 
 
Long-term assets:
 
 
 
Contingent redemption features - Series A Preferred Stock
28,608

 
42,140

Current liabilities:
 
 
 
Interest rate swaps
123

 
179

Cross currency and interest rate swaps

 
4,279

  Long-term liabilities:
 
 
 
Cross currency and interest rate swaps
8,130

 
7,939

Total derivative instrument assets
$
41,341

 
$
48,186

Total derivative instrument liabilities
$
14,895

 
$
13,848

Summary of unrealized gain (loss) recorded in and reclassified from accumulated comprehensive income (loss)
The table below shows the total recorded unrealized gain (loss) in Comprehensive income (loss) for the derivatives designated as hedging instruments. The impact of these derivative instruments on Comprehensive income (loss), Interest expense and AOCI for the three months ended March 31, 2018, and 2017 were as follows:

 
Gain (Loss) Recognized in Comprehensive Income (Effective Portion)
 Income Statement Location
 
Loss Reclassified
from AOCI to Income
(Effective Portion)
 
2018
 
2017
 
 
2018
 
2017
Interest rate swaps
$
6,688

 
$
2,592

 
 Interest expense
 
$
(297
)
 
$
(2,687
)
Net investment cross currency swaps
(4,478
)
 

 
N/A
 

 

Total
$
2,210

 
$
2,592

 

 
$
(297
)
 
$
(2,687
)

Components of the reported gain (loss) on derivatives not designated as hedging instruments
Components of the reported (Loss) gain on derivatives not designated as hedging instruments in the Consolidated Statements of Operations were as follows:
For the three months ended March 31,
2018
 
2017
Unrealized (Loss) Gain
 
 
 
Contingent redemption features - Series A Preferred
$
(13,533
)
 
$
12,223

Cross currency and interest rate swaps
4,305

 
18

Interest rate swaps
56

 
26

 
(9,172
)
 
12,267

Realized Loss
 
 
 
Cross currency and interest rate swaps
(10,168
)
 
(120
)
 
(10,168
)
 
(120
)
Total (Loss) Gain
 
 
 
Contingent redemption features - Series A Preferred
(13,533
)
 
12,223

Cross currency and interest rate swaps
(5,863
)
 
(102
)
Interest rate swaps
56

 
26

(Loss) gain on derivatives, net
$
(19,340
)
 
$
12,147